REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $310,000 | -8.0% | 1,160 | -0.8% | 0.02% | -10.5% |
| Q3 2021 | $337,000 | +67.7% | 1,169 | +15.7% | 0.02% | +72.7% |
| Q2 2021 | $201,000 | +3.6% | 1,010 | +1.0% | 0.01% | -8.3% |
| Q1 2021 | $194,000 | +1.6% | 1,000 | 0.0% | 0.01% | -7.7% |
| Q4 2020 | $191,000 | +29.9% | 1,000 | 0.0% | 0.01% | +18.2% |
| Q3 2020 | $147,000 | +19.5% | 1,000 | 0.0% | 0.01% | +10.0% |
| Q2 2020 | $123,000 | +28.1% | 1,000 | 0.0% | 0.01% | +11.1% |
| Q1 2020 | $96,000 | +4.3% | 1,000 | 0.0% | 0.01% | +28.6% |
| Q4 2019 | $92,000 | +21.1% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $76,000 | -10.6% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $85,000 | +44.1% | 1,000 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $59,000 | +11.3% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $53,000 | -3.6% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $55,000 | +17.0% | 1,000 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $47,000 | +30.6% | 1,000 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $36,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |